Keyphrases
Acetylcholine
8%
Acute Administration
10%
Adolescent Learning
68%
Aminopeptidase
10%
Aminopeptidase Activity
10%
Angiotensin II (Ang II)
8%
Angiotensin IV
100%
Angiotensin Receptor Antagonists
5%
Antagonism
5%
AT4 Receptor
17%
Attention Deficit Hyperactivity Disorder
5%
Autism Spectrum Disorder
5%
Beneficial Effects
8%
Biochemical Assay
5%
Biochemical Markers
5%
Biochemical Parameters
5%
Birth Timing
5%
Cardiovascular Drugs
8%
Clinical Pharmacology
5%
Cognitive Effects
73%
Cognitive Enhancement
5%
Cognitive Performance
5%
Diagnostic Criteria
5%
Diagnostic Tool
5%
Differential Degree
5%
Differential Diagnosis
5%
Dopamine
8%
Drug Development Program
8%
Early Alzheimer's Disease
5%
Enhancing Agents
5%
Enzyme Activity
10%
Europe
5%
Extracellular Matrix Protein 1 (ECM1)
8%
Facial Anomalies
5%
Fatty Acid Ethyl Esters
5%
Fetal Alcohol Spectrum Disorder
68%
Genetic Differences
8%
Glucose Uptake
8%
Grice
5%
Growth Retardation
5%
Hair Analysis
5%
Healthy Adults
10%
Human Population
5%
Human Remains
8%
Impaired Learning
10%
Impaired Memory
10%
Insulin-regulated Aminopeptidase
22%
International Journals
5%
Intervention Strategies
5%
Intrauterine Alcohol Exposure
5%
IRAP
21%
Italy
5%
King
5%
Learning Disabilities
5%
Learning Impairment
5%
Learning Model
8%
Leucine Aminopeptidase
8%
Losartan
10%
Maternal Hair
5%
Mechanism of Action
8%
Meconium
5%
Memory Models
8%
Metabolism
8%
Mouse Model
10%
Neonate
15%
Neuroprotective Peptide
8%
Neuropsychopharmacology
5%
Neuroscience
10%
Novel Object Recognition
5%
Novel Therapies
5%
Oxytocin
10%
Oxytocinase
8%
Payne
5%
Pharmacology
10%
Physostigmine
5%
Plasma Enzymes
5%
Predictive Validity
5%
Prenatal Alcohol
68%
Prenatal Alcohol Exposure
26%
Prenatal Exposure to Ethanol
10%
Psychopharmacology
5%
Renin-angiotensin System
8%
Retrospective Diagnosis
5%
Scopolamine
5%
Sex Differences
5%
Silvae
5%
Strain Differences
13%
Structural Brain Abnormalities
5%
Sweden
10%
Targeted Intervention
5%
Uppsala
10%
Vasodilator
8%
Washington
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylcholine
8%
Alzheimer's Disease
5%
Aminopeptidase
43%
Angiotensin
8%
Angiotensin II
8%
Angiotensin II [3-8]
100%
Angiotensin Receptor Antagonist
5%
Attention Deficit Disorder
5%
Autism
5%
Biochemical Marker
5%
Cardiovascular Agent
8%
Clinical Pharmacology
5%
Cystyl Aminopeptidase
8%
Cytosol Aminopeptidase
8%
Drug Development
8%
Ethanol
68%
Face Malformation
5%
Fatty Acid Ester
5%
Fetal Alcohol Syndrome
68%
Growth Retardation
5%
Hair Analysis
5%
Learning Disorder
21%
Losartan
10%
Mouse
21%
Mouse Model
10%
Oxytocin
10%
Physostigmine
5%
Prenatal Exposure
10%
Psychopharmacology
5%
Receptor
17%
Renin
8%
Scopolamine
5%
Neuroscience
Acetylcholine
8%
Alzheimer's Disease
5%
Aminopeptidase
43%
Angiotensin
8%
Angiotensin II
8%
Angiotensin II [3-8]
100%
Angiotensin Receptor
5%
Attention Deficit Hyperactivity Disorder
5%
Brain Abnormalities
5%
Cognitive Effect
13%
Cystyl Aminopeptidase
8%
Differential Diagnosis
5%
Eicosanoid Receptor
17%
Enzyme Activity
10%
Ethyl Ester
5%
Extracellular Matrix
8%
Fatty Acids
5%
Fetal Alcohol Spectrum Disorder
68%
Glucose Transport
8%
Learning Disabilities
21%
Leucyl Aminopeptidase
8%
Losartan
10%
Metabolic Pathway
8%
Neuroscience
10%
Oxytocin
10%
Pervasive Developmental Disorder
5%
Physostigmine
5%
Psychopharmacology
5%
Receptor Antagonist
5%
Renin
8%
Scopolamine
5%
Vasoconstrictors
8%